drugset / Trial / NCT00338507

Phase 2 Study - Erdosteine in Patients With CB/COPD

NCT00338507

Phase 2 Completed 400 enrolled Adams Respiratory Therapeutics
RandomizedParallel-groupDouble-blindTreatment

Summary

This clinical study is designed to explore dose ranging and identify methods to demonstrate the efficacy of Erdosteine in patients with stable Chronic Bronchitis associated with Chronic Obstructive Pulmonary Disease.

Timeline

Start
2006-03
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Erdosteine Small molecule

Indications